Benchling

Cloud-based platform for life sciences R&D

San Francisco, California, United States

Visit Website View Jobs

About Benchling

Benchling offers a platform for life sciences research and development, serving biotech and pharmaceutical companies, academic institutions, and research organizations. Its cloud-based tools, including an electronic lab notebook and molecular biology tools, help scientists manage data, collaborate, and streamline workflows. The company operates on a subscription model with various pricing tiers and additional premium features, setting it apart from competitors. Benchling's goal is to enhance the efficiency of scientific research, enabling clients to accelerate their innovations.

San Francisco, CaliforniaHeadquarters
2012Year Founded
$400.7MTotal Funding
SERIES_FCompany Stage
Enterprise Software, BiotechnologyIndustries
501-1,000Employees

Benefits

Four months of fully paid parental leave
401(k) plan
Remote working stipend
Yearly company-wide retreat
Monthly gym and wellness stipend
Commuter benefits
100% premiums covered for health, dental, and vision
Weekly company social events
Flexible PTO and company-wide winter holiday shutdown

Risks

Emerging biotech software platforms could erode Benchling's market share.
Rapid AI advancements may require significant investment to maintain competitiveness.
Data privacy concerns could undermine trust in Benchling's platform.

Differentiation

Benchling offers a comprehensive cloud-based platform for life sciences R&D.
The platform integrates AI and machine learning for advanced research capabilities.
Benchling's tools facilitate collaboration and data sharing across global scientific teams.

Upsides

Benchling's acquisition of PipeBio enhances AI-powered antibody discovery capabilities.
Partnerships with companies like Sanofi accelerate digital transformation in pharmaceutical R&D.
Growing demand for cloud-based solutions boosts Benchling's market potential.

Funding

Total raised$400.67 M
Latest valuation$6.10 B
StageSERIES_F
SERIES F
10/31/2021
$100
$6.10 B
SERIES E
3/31/2021
$200
$4.00 B
SERIES D
4/30/2020
$50
$850.00 M
SERIES C
6/30/2019
$34
$172.50 M
SERIES B
5/31/2018
$14
$72.50 M
SERIES A
9/30/2016
$7
$35.00 M
SEED
3/31/2015
$5
$25.00 M
SUPPORT PROGRAM
6/30/2012
N/A